Vir Biotechnology Inc (VIR)

NASDAQ
36.89
-0.46(-1.23%)
After Hours
36.89
0.00(0.00%)
- Real-time Data
  • Volume:
    458,161
  • Bid/Ask:
    36.50/37.25
  • Day's Range:
    36.10 - 37.41

VIR Overview

Prev. Close
37.35
Day's Range
36.1-37.41
Revenue
72.63M
Open
37.35
52 wk Range
25.32-140.02
EPS
-3.1
Volume
458,161
Market Cap
4.8B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
705,791
P/E Ratio
-
Beta
-
1-Year Change
-24.85%
Shares Outstanding
130,039,838
Next Earnings Date
Aug 05, 2021
What is your sentiment on Vir Biotechnology Inc?
or
Market is currently closed. Voting is open during market hours.

Vir Biotechnology Inc News

Vir Biotechnology Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellNeutral
Technical IndicatorsStrong BuyBuyStrong SellStrong SellBuy
SummaryNeutralNeutralStrong SellStrong SellNeutral

Vir Biotechnology Inc Company Profile

Vir Biotechnology Inc Company Profile

Employees
340

Vir Biotechnology, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments to treat and prevent serious infectious diseases. Its technology platforms are focused on antibodies, T cells, innate immunity and small interfering ribonucleic acid (siRNA). Its pipeline consists of product candidates targeting hepatitis B virus (HBV), influenza A, human immunodeficiency virus (HIV) and tuberculosis (TB). Its product candidates include VIR-2218, VIR-3434, VIR-2482, VIR-1111 and VIR-2020. The Company is developing VIR-2218 and VIR-3434 for the functional cure of HBV. VIR-2218 is a subcutaneously administered HBV-targeting siRNA. VIR-3434 is a subcutaneously administered HBV-neutralizing monoclonal antibody (mAb). VIR-2482 is an intramuscularly administered influenza A-neutralizing mAb. VIR-1111 is a subcutaneously administered HIV T cell vaccine. VIR-2020 is a subcutaneously administered TB T cell vaccine.

Read More
  • Now invest in gold
    1
    • silver will Rise high...
      1
  • 5 rates buy vs 2 sell
    0
    • 100 today it will go back previous levels
      3
      • News out today apparently it turns out Vir-7831 reduce hospitalization by 85%. Please explain me why just last week it was a failure.....I feel for those that sold out, there should be a dramatic rise in sp today. Glad I am not invested here.
        1
        • I bought the drop :D
          0
      • In my opinion the expectation of great success for VIR is already included in the price. At the moment VIR Market Cap 10.5B takes these perspectives into account. There will be a real result - get a capitalization of 40 billion. But who will be the next rocket after VIR?
        0
        • Market Cap was 6B yesterday, while Vir was 75% undervalued considering its fair value of 24B according to simplewall.st
          0
        • *simplywall.st
          0
      • This stock have a lot of potiential, HBV and 2 corona treatments with positive phase 3 result. The bank people want to downgrate the stock so they can buy in the dip and afterwards upgrate. Buy now or you will regrets.
        0
        • Alpha Pro Tech, Ltd. (APT), made face mask, up 16%
          0
          • Go vir👍
            0
            • This is only the first good news about HBV treatment. They still have covid treatment in phase 3 with positive result and then it comes out this stock gonna rally to the moon.
              0
              • This stock will rally in the next few month, buy today before its late.
                0
                • Dung Pham which other stocks you have faith , we follow !
                  0
                • Joyce YunI’m also long in moderna and biontech since marts 20. They are both making disruption in biotech technology.
                  0
                • tq for sharing =) biotechnology stocks are scarily volatile . anything outside biotechnology worth a look
                  0
              • Some good news?
                0
                • Tonix Pharmaceuticals Holding Corp. Vaccine Genome Researchers Report 99.7% Colinear Identity Between a U.S. Civil War Era Smallpox Vaccine and Horsepox Virus
                  0
                  • VIR. Interesting company and approach to Covid. On our radar. Last: $33.
                    0
                    • this is going to go well up in the short run
                      1
                      • hello, what do you think why is it falling?
                        1
                        • Great, they have testing on July 1st, it will lift
                          0
                          • what do you think about that stock?
                            0
                            • this stock is a curse
                              0
                              • the usual ****
                                0
                                • Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment 05/29/20 at 8:00 AM EDT
                                  1
                                  • buuuuuuuuu!
                                    0
                                    • Well they are riding the covid bandwagon. All biotechs are so lets see if they can finish
                                      0
                                      • what happened to this stock today?  What's the news behind to this drop? Just a cash out after yesterday's run?
                                        1
                                        • does that firm have potential?
                                          2
                                          • day trader here
                                            0
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.